Navigation Links
Abstracts for the EORTC-NCI-AACR Symposium in Berlin go up online on Friday, Oct. 29
Date:10/27/2010

The majority of the abstracts to be presented at the EORTC-NCI-AACR [1] Symposium on "Molecular targets and cancer therapeutics" will go up online two weeks before the meeting at 00.01 hrs CET on Friday 29 October. The Symposium takes place in Berlin on 16-19 November.

Journalists are free to report on the online abstracts from the time that they go up online before the Symposium; however, they should bear in mind that all the abstracts had to be submitted by 15 June, and by the time the research will be presented to the Symposium in November some of the data and results may have changed.

Some abstracts, including late breaking abstracts and those that form part of the media programme, are not being published online before the Symposium begins. They will be published in a supplement abstract book available at the Symposium and will be posted online on the day of their presentation to the meeting; they will be embargoed to 00.01 hrs (CET) on those days.

The online abstracts can be found at: http://www.ecco-org.eu/Conferences-and-Events/EORTC-NCI-AACR-2010/Abstracts-online/page.aspx/2528

This Symposium, organised jointly by the European Organisation for the Research and Treatment of Cancer, the US National Cancer Institute and the American Association for Cancer Research, offers the media:

  • Cutting edge information on new cancer drug research and development from experts in Europe, North America, Asia and Australia;
  • Free registration for bona fide media with official press credentials (press card and/or a commissioning letter on headed paper from the editor of the journal/website they represent);
  • All sessions open to journalists;
  • Media centre with free computing, international phones, and internet.

Around 2,200 international experts in cancer research will present and discuss recent advances in the early development of promising new compounds in different stages of pre-clinical and clinical research.


'/>"/>

Contact: Emma Mason
wordmason@mac.om
ECCO-the European CanCer Organisation
Source:Eurekalert

Related biology news :

1. Call for abstracts and registration for the EMBO Meeting 2009
2. Record number of abstracts received for the World Congress on Osteoporosis 2010 -- IOF WCO-ECCEO10
3. Call for abstracts and registration the EMBO Meeting 2010
4. 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
5. Penn presents inaugural symposium on applied mathematics and computational science
6. AVS 55th International Symposium & Exhibition, Oct. 19-24
7. Counter-terrorism symposium held at NJIT tomorrow
8. The Camille & Henry Dreyfus Foundation to host important symposium on chemistry and the environment
9. CTRC-AACR San Antonio Breast Cancer Symposium
10. Childrens National convenes first childhood obesity symposium
11. Survival in a Changing World: The Journal of Experimental Biology 2009 symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
(Date:4/19/2016)... 20, 2016 The new GEZE ... compact web-based "all-in-one" system solution for all door components. ... or the door interface with integration authorization management system, ... systems. The minimal dimensions of the access control and ... building installations offer considerable freedom of design with regard ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, ... microbial test has received AOAC Research Institute approval 061601. , “This is another ... year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel ...
(Date:6/23/2016)... ... , ... Supplyframe, the Industry Network for electronics hardware design ... Located in Pasadena, Calif., the Design Lab’s mission is to bring together inventors ... and brought to market. , The Design Lab is Supplyframe’s physical representation of ...
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a company ... to the medical community, has closed its Series A ... Nunez . "We have received a commitment ... capital we need to meet our current goals," stated ... us the runway to complete validation on the current ...
Breaking Biology Technology: